Chordomas of the craniospinal axis: multimodality surgical, radiation and medical management strategies

References

• Cesinaro AM, Maiorana A, Collina G, Fano RA. Extra-axial chordoma. Report of a case with immunohistochemical study. Pathologica85, 755–760 (1993).
   PubMedGoogle Scholar
• Lu CY, Chai CY, Chiang IC. Chordoma mimicking the trigeminal schwannoma: a case report. Clin. Imaging28, 187–190 (2004).
   PubMedGoogle Scholar
• DiFrancesco LM, Davanzo Castillo CA, Temple WJ. Extra-axial chordoma. Arch. Pathol. Lab. Med.130, 1871–1874 (2006).
   PubMedGoogle Scholar
• Currier BL, Papagelopoulos PJ, Krauss WE, Unni KK, Yaszemski MJ. Total en bloc spondylectomy of C5 vertebra for chordoma. Spine32, E294–E299 (2007).
   Google Scholar
• Kendall BE. Cranial chordomas. Br. J. Radiol.50, 687–698 (1977).
   PubMed Web of Science ®Google Scholar
• Azzarelli A, Quagliuolo V, Cerasoli S et al. Chordoma: natural history and treatment results in 33 cases. Eur. J. Surg. Oncol.37, 185–191 (1988).
   Google Scholar
• Lanzino G, Dumont AS, Lopes MB, Laws ER Jr. Skull base chordomas: overview of disease, management options, and outcome. Neurosurg. Focus10, E12 (2001).
   Google Scholar
• Campbell WM, McDonald TJ, Unni KK, Laws ER Jr. Nasal and paranasal presentations of chordomas. Laryngoscope90, 612–618 (1980).
   PubMedGoogle Scholar
• Higinbotham NL, Phillips RF, Farr HW, Hustu HO. Chordoma. Thirty-five-year study at Memorial Hospital. Cancer20, 1841–1850 (1967).
   PubMed Web of Science ®Google Scholar
• O’Connell JX, Renard LG, Liebsch NJ, Efird JT, Munzenrider JE, Rosenberg AE. Base of skull chordoma. A correlative study of histologic and clinical features of 62 cases. Cancer74, 2261–2267 (1994).
   PubMedGoogle Scholar
• Arnold H, Herrmann HD. Skull base chordoma with cavernous sinus involvement. Partial or radical tumour-removal? Acta Neurochir. (Wien)83, 31–37 (1986).
   PubMed Web of Science ®Google Scholar
• Sekhar LN, Møller AR. Operative management of tumors involving the cavernous sinus. J. Neurosurg.64, 879–889 (1986).
   PubMedGoogle Scholar
• Lanzino G, Hirsch WL, Pomonis S, Sen CN, Sekhar LN. Cavernous sinus tumors: neuroradiologic and neurosurgical considerations on 150 operated cases. J. Neurosurg. Sci.36, 183–196 (1992).
   PubMedGoogle Scholar
• Lanzino G, Sekhar LN, Hirsch WL, Sen CN, Pomonis S, Snyderman CH. Chordomas and chondrosarcomas involving the cavernous sinus: review of surgical treatment and outcome in 31 patients. Surg. Neurol.40, 359–371 (1993).
   PubMedGoogle Scholar
• Goel A, Muzumdar DP, Nitta J. Surgery on lesions involving cavernous sinus. J. Clin. Neurosci.8, 71–77 (2001).
   PubMedGoogle Scholar
• Fleming RA, Wilson MW, Fuller CE, Fleming JC, Haik BG. Clinical and pathological features of intracranial chordoma with orbital involvement in a child. Ophthal. Plast. Reconstr. Surg.19, 240–242 (2003).
   PubMedGoogle Scholar
• al-Mefty O, Borba LA. Skull base chordomas: a management challenge. J. Neurosurg.86, 182–189 (1997).
   PubMed Web of Science ®Google Scholar
• Chandawarkar RY. Sacrococcygeal chordoma: review of 50 consecutive patients. World J. Surg.20, 717–719 (1996).
   PubMed Web of Science ®Google Scholar
• Cheng EY, Ozerdemoglu RA, Transfeldt EE, Thompson RC Jr. Lumbosacral chordoma. Prognostic factors and treatment. Spine24, 1639–1645 (1999).
   PubMed Web of Science ®Google Scholar
• York JE, Kaczaraj A, Abi-Said D et al. Sacral chordoma: 40-year experience at a major cancer center. Neurosurgery44, 74–79 (1999).
   PubMed Web of Science ®Google Scholar
• Fourney DR, Gokaslan ZL. Current management of sacral chordoma. Neurosurg. Focus15, E9 (2003).
   Google Scholar
• Heffelfinger MJ, Dahlin DC, MacCarty CS, Beabout JW. Chordomas and cartilaginous tumors at the skull base. Cancer32, 410–420 (1973).
   PubMed Web of Science ®Google Scholar
• O'Neill P, Bell BA, Miller JD, Jacobson I, Guthrie W. Fifty years of experience with chordomas in southeast Scotland. Neurosurgery16, 166–170 (1985).
   PubMed Web of Science ®Google Scholar
• McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM. Chordoma: incidence and survival patterns in the United States, 1973–1995. Cancer Causes Control12(1), 1–11 (2001).
   PubMed Web of Science ®Google Scholar
• Barnes L, Kapadia SB. The biology and pathology of selected skull base tumors. J. Neurooncol.20(3), 213–240 (1994).
   PubMedGoogle Scholar
• Sundaresan N, Huvos AG, Krol G, Lane JM, Brennan M. Surgical treatment of spinal chordomas. Arch. Surg.122(12), 1479–1482 (1987).
   PubMed Web of Science ®Google Scholar
• Brandal P, Bjerkehagen B, Danielsen H, Heim S. Chromosome 7 abnormalities are common in chordomas. Cancer Genet. Cytogenet.160(1), 15–21 (2005).
   PubMedGoogle Scholar
• Riva P, Crosti F, Orzan F et al. Mapping of candidate region for chordoma development to 1p36.13 by LOH analysis. Int. J. Cancer107(3), 493–497 (2003).
   PubMed Web of Science ®Google Scholar
• Klingler L, Shooks J, Fiedler PN, Marney A, Butler MG, Schwartz HS. Microsatellite instability in sacral chordoma. Eur. J. Surg. Oncol.73(2), 100–103 (2000).
   Google Scholar
• Kelley MJ, Korczak JF, Sheridan E, Yang X, Goldstein AM, Parry DM. Familial chordoma, a tumor of notochordal remnants, is linked to chromosome 7q33. Am. J. Hum. Genet.69(2), 454–460 (2001).
   PubMedGoogle Scholar
• Weinberger PM, Yu Z, Kowalski D et al. Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignancies. Arch. Otolaryngol. Head Neck Surg.131(8), 707–711 (2005).
   PubMed Web of Science ®Google Scholar
• Tamborini E, Miselli F, Negri T et al. Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR)B, PDGFRA, and KIT receptors in chordomas. Clin. Cancer Res.12(23), 5928–6920 (2006).
   Google Scholar
• Mori K, Chano T, Kushima R, Hukuda S, Okabe H. Expression of E-cadherin in chordomas: diagnostic marker and possible role of tumor cell affinity. Virchows Arch.440(2), 123–127 (2002).
   PubMedGoogle Scholar
• Saad AG, Collins MH. Prognostic value of MIB-1, E-cadherin, and CD44 in pediatric chordomas. Pediatr. Dev. Pathol.8(3), 362–368 (2005).
   PubMedGoogle Scholar
• Pallini R, Maira G, Pierconti F et al. Chordoma of the skull base: predictors of tumor recurrence. J. Neurosurg.98(4), 812–822 (2003).
   PubMedGoogle Scholar
• Colli B, al-Mefty O. Chordomas of the craniocervical junction: follow-up review and prognostic factors. J. Neurosurg.95, 933–943 (2001).
   PubMed Web of Science ®Google Scholar
• Crockard HA, Steel T, Plowman N et al. A multidisciplinary team approach to skull base chordomas. J. Neurosurg.95, 175–183 (2001).
   PubMed Web of Science ®Google Scholar
• Sekhar LN, Pranatartiharan R, Chanda A, Wright DC. Chordomas and chondrosarcomas of the skull base: results and complications of surgical management. Neurosurg. Focus10, E2 (2001).
   Google Scholar
• Tzortzidis F, Elahi F, Wright D, Natarajan SK, Sekhar LN. Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chordomas. Neurosurgery59, 230–237 (2006).
   PubMed Web of Science ®Google Scholar
• Chetty R, Levin CV, Kalan MR. Chordoma: a 20-year clinicopathologic review of the experience at Groote Schuur Hospital, Cape Town. Eur. J. Surg. Oncol.46, 261–264 (1991).
   Google Scholar
• Moriki T, Takahashi T, Wada M, Ueda S, Ichien M, Miyazaki E. Chondroid chordoma: fine-needle aspiration cytology with histopathological, immunohistochemical, and ultrastructural study of two cases. Diagn. Cytopathol.21, 335–339 (1999).
   PubMed Web of Science ®Google Scholar
• Rosenberg AE, Bhan AK, Lee JM. Chondroid chordoma. Am. J. Clin. Pathol.104, 484 (1995).
   PubMedGoogle Scholar
• Weber AL, Liebsch NJ, Sanchez R, Sweriduk ST, Jr. Chordomas of the skull base. Radiologic and clinical evaluation. Neuroimaging Clin. N. Am.4, 515–527 (1994).
   PubMedGoogle Scholar
• Tamaki N, Nagashima T, Ehara K, Motooka Y, Barua KK. Surgical approaches and strategies for skull base chordomas. Neurosurg. Focus10, E9 (2001).
   Google Scholar
• al-Mefty O, Anand VK. Zygomatic approach to skull-base lesions. J. Neurosurg.73, 668–673 (1990).
   PubMed Web of Science ®Google Scholar
• Babu RP, Sekhar LN, Wright DC. Extreme lateral transcondylar approach: technical improvements and lessons learned. J. Neurosurg.81, 49–59 (1994).
   PubMedGoogle Scholar
• Davis AE, Robin PE. Transpalatal approach to the petrous apex. J. Laryngol. Otol.103, 94–96 (1989).
   PubMedGoogle Scholar
• Day JD, Fukushima T, Giannotta SL. Microanatomical study of the extradural middle fossa approach to the petroclival and posterior cavernous sinus region: description of the rhomboid construct. Neurosurgery34, 1009–1016 (1994).
   PubMed Web of Science ®Google Scholar
• Harsh GR, Sekhar LN. The subtemporal, transcavernous, anterior transpetrosal approach to the upper brain stem and clivus. J. Neurosurg.77, 709–717 (1992).
   PubMed Web of Science ®Google Scholar
• Kawase T, Shiobara R, Toya S. Anterior transpetrosal-transtentorial approach for sphenopetroclival meningiomas: surgical method and results in 10 patients. Neurosurgery28, 869–875 (1991).
   PubMed Web of Science ®Google Scholar
• Kingdom TT, Nockels RP, Kaplan MJ. Transoral-transpharyngeal approach to the craniocervical junction. Otolaryngol. Head Neck Surg.113, 393–400 (1995).
   PubMedGoogle Scholar
• Lawton MT, Daspit CP, Spetzler RF. Transpetrosal and combination approaches to skull base lesions. Clin. Neurosurg.43, 91–112 (1996).
   PubMedGoogle Scholar
• Miller CG, van Loveren HR, Keller JT, Pensak M, el-Kalliny M, Tew JM Jr. Transpetrosal approach: surgical anatomy and technique. Neurosurgery33, 461–469 (1993).
   PubMedGoogle Scholar
• Sekhar LN, Janecka IP, Jones NF. Subtemporal–infratemporal and basal subfrontal approach to extensive cranial base tumours. Acta Neurochir. (Wien)92, 83–92 (1988).
   PubMedGoogle Scholar
• Sekhar LN, Nanda A, Sen CN, Snyderman CN, Janecka IP. The extended frontal approach to tumors of the anterior, middle and posterior skull base. J. Neurosurg.76, 198–206 (1992).
   PubMed Web of Science ®Google Scholar
• Sekhar LN, Pomeranz S, Sen CN. Extradural petrous bone and petroclival neoplasms. Acta Neurochir. Suppl. (Wien)53, 183–192 (1991).
   PubMedGoogle Scholar
• Sen CN, Sekhar LN. An extreme lateral approach to intradural lesions of the cervical spine and foramen magnum. Neurosurgery27, 197–204 (1990).
   PubMedGoogle Scholar
• Sen CN, Sekhar LN. The subtemporal and preauricular infratemporal approach to intradural structures ventral to the brain stem. J. Neurosurg.73, 345–354 (1990).
   PubMedGoogle Scholar
• Tummala RP, Coscarella E, Morcos JJ. Transpetrosal approaches to the posterior fossa. Neurosurg. Focus19, E6 (2005).
   Google Scholar
• Tzortzidis F, Bejjani G, Papadas T et al. Craniofacial osteotomies to facilitate resection of large tumours of the anterior skull base. J. Craniomaxillofac. Surg.24, 224–229 (1996).
   PubMedGoogle Scholar
• Gonzalez LF, Crawford NR, Horgan MA, Deshmukh P, Zabramski JM, Spetzler RF. Working area and angle of attack in three cranial base approaches: pterional, orbitozygomatic, and maxillary extension of the orbitozygomatic approach. Neurosurgery50, 550–555 (2002).
   PubMed Web of Science ®Google Scholar
• Zabramski JM, Kiris T, Sankhla SK, Cabiol J, Spetzler RF. Orbitozygomatic craniotomy. Technical note. J. Neurosurg.89, 336–341 (1998).
   PubMed Web of Science ®Google Scholar
• al-Mefty O, Borba LA, Aoki N, Angtuaco E, Pait TG. The transcondylar approach to extradural nonneoplastic lesions of the craniovertebral junction. J. Neurosurg.84, 1–6 (1996).
   PubMedGoogle Scholar
• Tedeschi H, Rhoton AL Jr. Lateral approaches to the petroclival region. Surg. Neurol.41, 180–216 (1994).
   PubMedGoogle Scholar
• Forsyth PA, Cascino TL, Shaw EG et al. Intracranial chordomas: a clinico pathological and prognostic study of 51 cases. J. Neurosurg.78, 741–747 (1993).
   PubMed Web of Science ®Google Scholar
• Gay E, Sekhar LN, Rubinstein E et al. Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients. Neurosurgery36, 887–896 (1995).
   PubMed Web of Science ®Google Scholar
• Sen C, Triana A. Cranial chordomas: results of radical excision. Neurosurg. Focus10, E3 (2001).
   Google Scholar
• Gray SW, Singhabhandhu B, Smith RA, Skandalakis JE. Sacrococcygeal chordoma: report of a case and review of the literature. Surgery78, 573–582 (1975).
   PubMedGoogle Scholar
• Ishii K, Chiba K, Watanabe M, Yabe H, Fujimura Y, Toyama Y. Local recurrence after S2–3 sacrectomy in sacral chordoma. Report of four cases. J. Neurosurg.97, 98–101 (2002).
   PubMedGoogle Scholar
• Samson IR, Springfield DS, Suit HD, Mankin HJ. Operative treatment of sacrococcygeal chordoma. A review of twenty-one cases. J. Bone Joint Surg. Am.75, 1476–1484 (1993).
   PubMedGoogle Scholar
• Yonemoto T, Tatezaki S, Takenouchi T, Ishii T, Satoh T, Moriya H. The surgical management of sacrococcygeal chordoma. Cancer85, 878–883 (1999).
   PubMedGoogle Scholar
• Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W, Meis-Kindblom JM. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer88, 2122–2134 (2000).
   PubMed Web of Science ®Google Scholar
• Fourney DR, Rhines LD, Hentschel SJ et al. En bloc resection of primary sacral tumors: classification of surgical approaches and outcome. J. Neurosurg. Spine3, 111–122 (2005).
   PubMed Web of Science ®Google Scholar
• Fourney DR, Gokaslan ZL. Spinal instability and deformity due to neoplastic conditions. Neurosurg. Focus14, E8 (2003).
   Google Scholar
• Jackson RJ, Gokaslan ZL. Spinal-pelvic fixation in patients with lumbosacral neoplasms. J. Neurosurg.92, 61–70 (2000).
   PubMed Web of Science ®Google Scholar
• Miles WK, Chang DW, Kroll SS et al. Reconstruction of large sacral defects following total sacrectomy. Plast. Reconstr. Surg.105, 2387–2394 (2000).
   PubMed Web of Science ®Google Scholar
• Fuchs B, Dickey ID, Yaszemski MJ, Inwards CY, Sim FH. Operative management of sacral chordoma. J. Bone Joint Surg. Am.87, 2211–2216 (2005).
   PubMed Web of Science ®Google Scholar
• Osaka S, Kodoh O, Sugita H, Osaka E, Yoshida Y, Ryu J. Clinical significance of a wide excision policy for sacrococcygeal chordoma. J. Cancer Res. Clin. Oncol.132, 213–218 (2006).
   PubMed Web of Science ®Google Scholar
• Baratti D, Gronchi A, Pennacchioli E et al. Chordoma: natural history and results in 28 patients treated at a single institution. Ann. Surg. Oncol.10, 291–296 (2003).
   PubMed Web of Science ®Google Scholar
• Hulen CA, Temple HT, Fox WP, Sama AA, Green BA, Eismont FJ. Oncologic and functional outcome following sacrectomy for sacral chordoma. J. Bone Joint Surg. Am.88, 1532–1539 (2006).
   PubMed Web of Science ®Google Scholar
• Todd LT, Yaszemski MJ, Currier BL, Fuchs B, Kim CW, Sim FH. Bowel and bladder function after major sacral resection. Clin. Orthop. Relat. Res.397, 36–39 (2002).
   PubMed Web of Science ®Google Scholar
• Biagini R, Ruggieri P, Mercuri M et al. Neurologic deficit after resection of the sacrum. Chir. Organi. Mov.82, 357–372 (1997).
   PubMedGoogle Scholar
• Gunterberg B, Kewenter J, Petersén I, Stener B. Anorectal function after major resections of the sacrum with bilateral or unilateral sacrifice of sacral nerves. Br. J. Surg.63, 546–554 (1976).
   PubMed Web of Science ®Google Scholar
• Nakai S, Yoshizawa H, Kobayashi S, Maeda K, Okumura Y. Anorectal and bladder function after sacrifice of the sacral nerves. Spine25, 2234–2239 (2000).
   PubMedGoogle Scholar
• Wuisman P, Lieshout O, Sugihara S, van Dijk M. Total sacrectomy and reconstruction: oncologic and functional outcome. Clin. Orthop. Relat. Res.381, 192–203 (2000).
   PubMedGoogle Scholar
• Gunterberg B, Romanus B, Stener B. Pelvic strength after major amputation of the sacrum. An exerimental study. Acta Orthop. Scand.47, 635–642 (1976).
   PubMed Web of Science ®Google Scholar
• Fuller DB, Bloom JG. Radiotherapy for chordoma. Int. J. Radiat. Oncol. Biol. Phys.15(2), 331–339 (1988).
   PubMed Web of Science ®Google Scholar
• Romero J, Cardenes H, La Torre A et al. Chordoma: results of radiation therapy in eighteen patients. Radiother. Oncol.29(1), 27–32 (1993).
   PubMedGoogle Scholar
• Catton C, O’Sullivan B, Bell R et al. Chordoma: long-term follow-up after radical photon irradiation. Radiother. Oncol.41, 67–70 (1996).
   PubMed Web of Science ®Google Scholar
• Zorlu F, Gurkaynak M, Yildiz F, Oke K, Atahan IL. Conventional external radiotherapy in the management of clivus chordomas with overt residual disease. Neurol. Sci.21, 203–207 (2000).
   PubMedGoogle Scholar
• Debus J, Schulz-Ertner D, Schad L et al. Stereotactic fractionated radiotherapy for chordomas and chondrosarcomas of the skull base. Int. J. Radiat. Oncol. Biol. Phys.47(3), 591–596 (2000).
   PubMed Web of Science ®Google Scholar
• Muthukumar N, Kondziolka D, Lunsford LD, Flickinger JC. Stereotactic radiosurgery for chordoma and chondrosarcoma: further experiences. Int. J. Radiat. Oncol. Biol. Phys.41(2), 387–392 (1998).
   PubMedGoogle Scholar
• Chang SD, Martin DP, Lee E, Adler JR. Stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for residual or recurrent cranial base and cervical chordomas. Neurosurg. Focus10(3), E5 (2001).
   Google Scholar
• Rhomberg W, Bohler F, Novak H, Dertinger S, Breitfellner G. A small prospective study of chordomas treated with radiotherapy and razoxane. Strahlenther. Onkol.179(4), 249–253 (2003).
   PubMed Web of Science ®Google Scholar
• Romberg W, Eiter H, Bohler F, Dertinger S. Combined radiotherapy and razoxane in the treatment of chondrosarcomas and chordomas. Anticancer Res.26, 2407–2411 (2006).
   PubMedGoogle Scholar
• Sharpe HBA, Field EO, Hellmann K. The mode of action of the cytostatic agent ICRF 159. Nature226, 524–526 (1970).
   PubMedGoogle Scholar
• Munzenrider JE, Liebsch NJ. Proton therapy for tumors of the skull base. Strahlenther. Onkol.175(Suppl. 2) 57–63 (1999).
   PubMed Web of Science ®Google Scholar
• Hug EG, Loredo LN, Slater JD et al. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J. Neurosurg.91, 432–439 (1999).
   PubMed Web of Science ®Google Scholar
• Noel G, Habrand JL, Mammar H et al. Combination of photon and proton radiation therapy for chordomas and chondrosarcomas of the skull base: the Centre de Protontherapie D’Orsay experience. Int. J. Radiat. Oncol. Biol. Phys.51(2), 392–398 (2001).
   PubMed Web of Science ®Google Scholar
• Noel G, Feuvret L, Calugaru V et al. Chordomas of the base of the skull and upper cervical spine. One hundred patients irradiated by a 3D conformal technique combining photon and proton beams. Acta Oncologica44, 700–708 (2005).
   PubMed Web of Science ®Google Scholar
• Debus J, Hug EB, Liebsch NJ et al. Brainstem tolerance to conformal radiotherapy of skull base tumors. Int. J. Radiat. Oncol. Biol. Phys.39(5), 967–975 (1997).
   PubMed Web of Science ®Google Scholar
• Santoni R, Liebsch N, Finkelstein DM et al. Temporal lobe (TL) damage following surgery and high-dose photon and proton irradiation in 96 patients affected by chordomas and chondrosarcomas of the base of the skull. Int. J. Radiat. Oncol. Biol. Phys.41(1), 59–68 (1998).
   PubMedGoogle Scholar
• Urie MM, Fullerton B, Tatsuzaki H et al. A dose response analysis of injury to cranial nerves and/or nuclei following proton beam radiation therapy. Int. J. Radiat. Oncol. Biol. Phys.23(1), 27–39 (1992).
   PubMed Web of Science ®Google Scholar
• Castro JR, Linstadt DE, Bahary JP et al. Experience in charged particle irradiation of tumors of the skull base: 1977–1992. Int. J. Radiat. Oncol. Biol. Phys.29(4), 647–655 (1994).
   PubMed Web of Science ®Google Scholar
• Schulz-Ertner D, Haberer T, Jakel O et al. Radiotherapy for chordomas and low-grade chondrosarcomas of the skull base with carbon ions. Int. J. Radiat. Oncol. Biol. Phys.53(1), 36–42 (2002).
   PubMedGoogle Scholar
• Schulz-Ertner D, Nikoghosyan A, Thilmann C et al. Resuls of carbon ion radiotherapy in 152 patients. Int. J. Radiat. Oncol. Biol. Phys.58(2), 631–640 (2004).
   PubMed Web of Science ®Google Scholar
• Amendola BE, Amendola MA, Oliver E, McClatchey KD. Chordoma: role of radiation therapy. Radiology158(3), 839–843 (1986).
   PubMed Web of Science ®Google Scholar
• Park L, DeLaney TF, Liebsch NJ et al. Sacral chordomas: impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor. Int. J. Radiat. Oncol. Biol. Phys.65(5), 1514–1521 (2006).
   PubMed Web of Science ®Google Scholar
• Rutz HP, Weber DC, Sugahara S et al. Extracranial chordoma: outcome in patients treated with function-preserving surgery followed by spot-scanning proton beam irradiation. Int. J. Radiat. Oncol. Biol. Phys.67(2), 512–520 (2007).
   PubMed Web of Science ®Google Scholar
• Schoenthaler R, Castro JR, Petti PL, Baken-Brown K, Phillips TL. Charged particle irradiation of sacral chordomas. Int. J. Radiat. Oncol. Biol. Phys.26(2), 291–298 (1993).
   PubMedGoogle Scholar
• Imai R, Kamada T, Tsuji H et al. Carbon ion radiotherapy for unresectable sacral chordomas. Clin. Cancer Res.10, 5741–5746 (2004).
   PubMed Web of Science ®Google Scholar
• McSweeney AJ, Sholl PR. Metastatic chordoma use of mechlorethamine (nitrogen mustard) in chordoma therapy. AMA Arch. Surg.79(1), 152–155 (1959).
   PubMedGoogle Scholar
• Razis DV, Tsatsaronis A, Kyriazides I, Triantafyllou D. Chordoma of the cervical spine treated with vincristine sulfate. J. Med.5(5), 274–277 (1974).
   PubMedGoogle Scholar
• Harwick RD, Miller AS. Craniocervical chordomas. Am. J. Surg.138(4), 512–516 (1979).
   PubMed Web of Science ®Google Scholar
• Pouillart P, Schwarzenberg L, Amiel JL et al. Chemotherapeutic combinations of mutually potentiating drugs. 3 – Application to primary tumors of the central nervous system. Nouv. Presse Med.4(10), 721–724 (1975).
   PubMedGoogle Scholar
• Spratt JS, Martin AE, McKeown J. Sacral chordoma: a case study and review. Eur. J. Surg. Oncol.18(1), 101–103 (1981).
   Google Scholar
• Meis JM, Raymond Ak, Evans HL, Charles RE, Giraldo AA. “Dedifferentiated” chordoma. A clinicopathologic and immunohistochemical study of three cases. Am. J. Surg. Pathol.11(7), 516–525 (1987).
   PubMed Web of Science ®Google Scholar
• Azzarelli A, Quagliuolo V, Cerasoli S et al. Chordoma: natural history and treatment results in 33 cases. Eur. J. Surg. Oncol.37(3), 185–191 (1988).
   Google Scholar
• Fleming GF, Heimann PS, Stephens JK et al. Dedifferentiated chordoma. Response to aggressive chemotherapy in two cases. Cancer72(3), 714–718 (1993).
   PubMed Web of Science ®Google Scholar
• Scimeca PG, James-Herry AG, Black KS, Kahn E, Weinblatt ME. Chemotherapeutic treatment for malignant chordoma in children. J. Pediatr. Hematol. Oncol.18(2), 237–240 (1996).
   PubMedGoogle Scholar
• Casali PG, Messina A, Stacchiotti S et al. Imatinib mesylate in chordoma. Cancer101(9), 2086–2097 (2004).
   PubMed Web of Science ®Google Scholar
• Chugh R, Dunn R, Zalupski MM et al. Phase II study of 9-nitro-comptothecin in patients with advanced chordoma or soft tissue sarcoma. J. Clin. Oncol.23(15), 3597–3607 (2005).
   PubMed Web of Science ®Google Scholar
• McPherson CM, Suki D, McCutcheon IE, Gokaslan ZL, Rhines LD, Mendel E. Metastatic disease from spinal chordoma: a 10-year experience. J. Neurosurg. Spine5(4), 277–280 (2006).
   PubMedGoogle Scholar
• Hof H, Welzel T, Debus J. Effectiveness of cetuximab/gefitinib in the therapy of a sacral chordomoa. Onkologie29(12), 572–574 (2006).
   PubMed Web of Science ®Google Scholar
• Schonegger K, Gelpi E, Prayer D et al. Recurrent and metastatic clivus chordoma: systemic palliative therapy retards disease progression. Anticancer Drugs16(10), 1139–1143 (2005).
   PubMedGoogle Scholar